Stay updated on Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with a standard error view and leaving the site chrome intact.
    Difference
    19%
    Check dated 2026-09-20T22:34:19.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page adds a 2018 NIH grant/contract funding note and updates the page revision to v3.6.6, removing the previous v3.6.5 reference.
    Difference
    0.0%
    Check dated 2026-08-30T21:57:41.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The Plain Language Summary section was removed from the Study Details page, eliminating the patient-friendly overview of the KEYLYNK-010 study and its aims. The page now relies on more technical sections to describe the trial.
    Difference
    0.0%
    Check dated 2026-08-16T15:50:02.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, signaling a platform update to the page. No trial data or content changes are indicated by this text.
    Difference
    0.0%
    Check dated 2026-08-09T11:08:02.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing Revision: v3.6.3, indicating a small update to the page's content and metadata.
    Difference
    0.0%
    Check dated 2026-07-25T17:56:43.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a minor update to the page's documentation or metadata. This change does not modify study details, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-07-04T13:21:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.